Bio-Techne and Refeyn have launched a combined workflow that integrates imaged capillary isoelectric focusing with mass photometry for the characterization of bispecific antibodies. This solution allows researchers to directly correlate charge variants with molecular weight and aggregation at single-molecule resolution within a four-hour window. By requiring only nanogram-level samples, the technology enables biotech professionals to identify manufacturing risks earlier and reduce the likelihood of costly late-stage failures in drug development.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
7
Ali NematiWritten by Ali
